Showing results (11-20 of 88) with videos related to

Sort By:
Pageof 9
Journal of Chemotherapy (Florence, Italy)|June 29, 2016
Impressive and durable response in a case of multiple relapsed mantle cell lymphoma treated with bortezomib and rituximabEmanuele Cencini, Susanna Guerrini, Maria Antonietta Mazzei, et al.
Current Oncology (Toronto, Ont.)|July 28, 2023
Tumor-Associated Macrophages in Multiple Myeloma: Key Role in Disease Biology and Potential Therapeutic ImplicationsEmanuele Cencini, Anna Sicuranza, Sara Ciofini, et al.
Journal of Chemotherapy (Florence, Italy)|December 11, 2023
Are small lymphocytic lymphoma and chronic lymphocytic leukemia the same disease? The unsolved dilemmaEmanuele Cencini, Natale Calomino, Anna Sicuranza, et al.
Anti-Cancer Agents in Medicinal Chemistry|October 5, 2016
Bruton Kinase Inhibitors in Chronic Lymphocytic LeukemiaAlessandro Gozzetti, Veronica Candi, Corrado Zuanelli Brambilla, et al.
European Journal of Haematology|December 31, 2015
Long-term remission in a case of plasmablastic lymphoma treated with COMP (cyclophosphamide, liposomal doxorubicin, vincristine, prednisone) and bortezomibEmanuele Cencini, Alberto Fabbri, Susanna Guerrini, et al.
Acta Clinica Belgica|December 8, 2017
Durable response after VNCOP-B and rituximab in an elderly patient with high-grade B-cell lymphomaEmanuele Cencini, Alberto Fabbri, Luana Schiattone, et al.
American Journal of Blood Research|January 25, 2021
Ibrutinib in association with venetoclax for the treatment of mantle-cell lymphoma: a multicenter case seriesAlberto Fabbri, Emanuele Cencini, Angela Giovanna Congiu, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 13, 2010
Weekly bortezomib, pegylated liposomal doxorubicin, and dexamethasone is a safe and effective therapy for elderly patients with relapsed/refractory multiple myelomaAlessandro Gozzetti, Alberto Fabbri, Stefania Oliva, et al.
Clinical Lymphoma & Myeloma|June 27, 2006
Activity of rituximab monotherapy in refractory splenic marginal zone lymphoma complicated with autoimmune hemolytic anemiaAlberto Fabbri, Alessandro Gozzetti, Stefano Lazzi, et al.
Haematologica|March 1, 2002
Combined therapy with amifostine plus erythropoietin for the treatment of myelodysplastic syndromesAlberto Grossi, Pellegrino Musto, Valeria Santini, et al.
Pageof 9